AAAAAA
Results: 51-56/56
Authors:
Hengstler, JG
Lange, J
Kett, A
Dornhofer, N
Meinert, R
Arand, M
Knapstein, PG
Becker, R
Oesch, F
Tanner, B
Citation: Jg. Hengstler et al., Contribution of c-erbB-2 and topoisomerase II alpha to chemoresistance in ovarian cancer, CANCER RES, 59(13), 1999, pp. 3206-3214
Authors:
Taylor, RN
Gagnon, M
Lange, J
Lee, T
Draut, R
Kujawski, E
Citation: Rn. Taylor et al., A prototype computer image-based Papanicolaou smear proficiency test, ACT CYTOL, 43(6), 1999, pp. 1045-1051
Authors:
Roth, AD
Herrmann, R
Morant, R
Borner, MM
Honegger, HP
Obrist, R
Bacchi, M
Lange, J
Alberto, P
Castiglione, M
Citation: Ad. Roth et al., Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: The SAKK experience, EUR J CANC, 34(13), 1998, pp. 2126-2128
Authors:
Lange, J
Leibundgut, C
Greenbaum, N
Schick, AP
Citation: J. Lange et al., Modelling high magnitude events in large arid catchments - a field based approach in Nahal Zin, Israel, IAHS-AISH P, (248), 1998, pp. 561-567
Authors:
Stieger, R
Thurnheer, M
Lange, J
Citation: R. Stieger et al., Morbid obesity: 130 consecutive patients with laparoscopic gastric banding(vol 128, pg 1239, 1998), SCHW MED WO, 128(50), 1998, pp. 2008-2008
Authors:
Karolak-Wojciechowska, J
Lange, J
Ksiazek, W
Gniewosz, M
Rump, S
Citation: J. Karolak-wojciechowska et al., Structure-activity relationship investigations of the modulating effect ofcore substituents on the affinity of pyrazoloquinolinone congeners for thebenzodiazepine receptor, FARMACO, 53(8-9), 1998, pp. 579-585